TALEN and CRISPR-Cas9 in Rice and Disease Control

被引：0
|
作者：
Yang, Bing [1 ]
机构：
[1] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA
来源：
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL | 2015年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
P-7
引用
收藏
页码：S15 / S15
页数：1
相关论文
共 50 条
  • [21] Developing a CRISPR-Cas9 gene drive for pest control
    McFarlane, G. R.
    Gorjanc, G.
    Proudfoot, C.
    Whitelaw, C. B. A.
    Lillico, S. G.
    TRANSGENIC RESEARCH, 2020, 29 (04) : 480 - 481
  • [22] MicroRNAs tame CRISPR-Cas9
    Jouravleva, Karina
    Zamore, Phillip D.
    NATURE CELL BIOLOGY, 2019, 21 (04) : 416 - 417
  • [23] CRISPR-Cas9 wins Nobel
    Strzyz, Paulina
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2020, 21 (12) : 714 - 714
  • [24] The invisible dance of CRISPR-Cas9
    Palermo, Giulia
    Ricci, Clarisse G.
    McCammon, J. Andrew
    PHYSICS TODAY, 2019, 72 (04) : 30 - 36
  • [25] CRISPR-Cas9 in cancer therapeutics
    Randhawa, Shubhchintan
    REPROGRAMMING THE GENOME: CRISPR-CAS-BASED HUMAN DISEASE THERAPY, 2021, 181 : 129 - 163
  • [26] CRISPR-Cas9 Structures and Mechanisms
    Jiang, Fuguo
    Doudna, Jennifer A.
    ANNUAL REVIEW OF BIOPHYSICS, VOL 46, 2017, 46 : 505 - 529
  • [27] Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases
    Renaud, Jean-Baptiste
    Boix, Charlotte
    Charpentier, Marine
    De Cian, Anne
    Cochennec, Julien
    Duvernois-Berthet, Evelyne
    Perrouault, Loic
    Tesson, Laurent
    Edouard, Joanne
    Thinard, Reynald
    Cherifi, Yacine
    Menoret, Severine
    Fontaniere, Sandra
    De Croze, Noemie
    Fraichard, Alexandre
    Sohm, Frederic
    Anegon, Ignacio
    Concordet, Jean-Paul
    Giovannangeli, Carine
    CELL REPORTS, 2016, 14 (09): : 2263 - 2272
  • [28] CRISPR-Cas9 technology: applications and human disease modelling
    Torres-Ruiz, Raul
    Rodriguez-Perales, Sandra
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 4 - 12
  • [29] Allergan dives into CRISPR-Cas9
    不详
    NATURE BIOTECHNOLOGY, 2017, 35 (04) : 296 - 296
  • [30] CRISPR-Cas9 as a Trojan horse
    Monte, Daniel F. M.
    MOLECULAR THERAPY, 2023, 31 (10) : 2817 - 2818
12345